0001203311-13-000092.txt : 20131114 0001203311-13-000092.hdr.sgml : 20131114 20131114190458 ACCESSION NUMBER: 0001203311-13-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131031 FILED AS OF DATE: 20131114 DATE AS OF CHANGE: 20131114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRACHMAN JONATHAN G CENTRAL INDEX KEY: 0001588467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 131222034 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-10-31 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001588467 DRACHMAN JONATHAN G 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 CMO & EVP, R & D Common Stock 2013-10-31 4 A 0 8100.0 0.0 A 51112 D These shares represent restricted stock units and will be settled in common stock upon vesting. Restricted stock units shall vest in full on October 31, 2016. Amount of securities beneficially owned include 40,400 Restricted Stock Units subject to vesting. Jonathan G. Drachman 2013-11-14